Report center

医疗器械行业2023年三季报总结及展望:优选估值合理+有改善预期+跌幅较大的龙头标的-20231108-华安证券

2023年三季报总结: 表现较好的细分领域: (1)康复设备:板块整体受医疗反腐政策影响较少,且疫情期间显著受损于招标采购延迟,龙头公司如翔宇医疗、诚益通均呈现超过50%收入增长。 (2)血管介入:心脏电生理、瓣膜类介入(外科瓣)、神经介入(如颅内带药支架)尽管2023Q3增速不及2023Q2,但在整个高耗板块仍表现最为亮眼。 (3)内镜诊疗设备:消化内镜的终端需求仍较为旺盛,国产龙头开立和澳华竞

No subject companies

Publishers

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

  1. 1华安证券Published by or linked to this institution1

No related industries

No related reports

← Back to knowledge graph